中文名：曲格列汀2;曲格列汀琥珀酸;2-[[6-[(3R)-3-氨基-1-哌啶基]-3,4-二氢-3-甲基-2,4-二氧代-1(2H)-嘧啶基]甲基]-4-氟-苯甲腈琥珀酸盐;-[[2'-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1'-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基;(R)-2-[[2,4-二氧代-3-甲基-6-(3-氨基-1-哌啶基)-1,2,3,4-四氢-1-嘧啶基]甲基]-4-氟苯腈琥珀酸盐;曲格列汀琥珀酸盐；
英文名：Trelagliptin succinate - SYR 111472 succinate | SYR 472;SRY-472;Telagliptin Succinate;Trelagliptin succinate, >=98%;2-[[6-[(3R)-3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile,butanedioicacid;Trelagliptin Succinate API;SYR-472 succinate;Butanedioic acid, compd. with 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile (1:1)；
类别：医药原料-;原料药-;降压降糖类;小分子抑制剂;小分子抑制剂，天然产物;医药原料药;降压降糖药;医药 降压降糖药;生物化工类-;原料药;曲格列汀琥珀酸盐;原料药（API）;医药中间体;-;Inhibitors;antidiabetic;Trelagliptin
关键字： 琥珀酸曲格列汀，Trelagliptin succinate